PI3K Pathways Summit 2021
Evvnt Promotion / evvnt
Archiv
24.08.2021 - 26.08.2021 Online
Time: 9:00 am - 5:00 pm
Kongressthemen
With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.
With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/783356-3?pid=4832
Speakers: Zoe Johnson, Chief Scientific Officer, iOnctura, James Garner, Chief Executive Officer and Managing Director, Kazia Therapeutics and more
Brochure: https://go.evvnt.com/783356-3?pid=4832
Speakers: Zoe Johnson, Chief Scientific Officer, iOnctura, James Garner, Chief Executive Officer and Managing Director, Kazia Therapeutics and more
Anfragen und Anmeldung:
https://go.evvnt.com/783356-0?pid=4832
Frau Anita Kelemen
Allgemeinmedizin, Onkologie
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
